Your browser doesn't support javascript.
loading
Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins.
Tussey, Lynda; Strout, Cynthia; Davis, Matthew; Johnson, Casey; Lucksinger, Gregg; Umlauf, Scott; Song, Langzhou; Liu, Ge; Abraham, Katalin; White, C Jo.
Afiliación
  • Tussey L; VaxInnate Corporation , Cranbury, New Jersey.
  • Strout C; Coastal Carolina Research , Mt. Pleasant, South Carolina.
  • Davis M; Rochester Clinical Research , New York.
  • Johnson C; Johnson County Clinical Trials , Lenexa, Kansas.
  • Lucksinger G; Tekton Research , Austin, Texas.
  • Umlauf S; VaxInnate Corporation , Cranbury, New Jersey.
  • Song L; VaxInnate Corporation , Cranbury, New Jersey.
  • Liu G; VaxInnate Corporation , Cranbury, New Jersey.
  • Abraham K; Merck, North Wales.
  • White CJ; Independent Consultant/Medical Monitor , Lower Gwynedd, Pennsylvania.
Open Forum Infect Dis ; 3(1): ofw015, 2016 Jan.
Article en En | MEDLINE | ID: mdl-26925433
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2016 Tipo del documento: Article